Nancy Kuntz
Neurology with Special Qualifications in Child Neurology · Chicago, ILNPI 1114999125
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $403,345 of the $502,602 with a category attached, or 80.3%. Sarepta Therapeutics, Inc. accounts for 73.7% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $139,584, 5.5 times the $25,217 reported in 2019. Among neurology with special qualifications in child neurology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $1500.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sarepta Therapeutics, Inc.$370K
- Genentech USA, Inc.$38K
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$30K
- Argenx US, Inc.$19K
- F. Hoffmann-la Roche AG$19K
- Biogen$13K
- plus $14K from 9 others
Across 474 payments — averaging $14,943 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$4.2M
- Sarepta Therapeutics, Inc.$2.1M
- Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$334K
- Argenx US, Inc.$213K
- Novartis$109K
- Hoffmann-la Roche Limited$52K
- plus $90K from 5 others
What the payments were for
- Consulting fees$403,34580%
- Speaking & faculty fees$39,1508%
- Travel & lodging$34,7167%
- Food & beverage$7,6902%
- Education$17,7024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sarepta Therapeutics, Inc. | 136 | $370,370 |
| Genentech USA, Inc. | 28 | $37,852 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 87 | $29,936 |
| Argenx US, Inc. | 24 | $18,954 |
| F. Hoffmann-la Roche AG | 5 | $18,531 |
| Biogen | 24 | $13,385 |
| Catalyst Pharmaceuticals, Inc. | 10 | $7,902 |
| Janssen Scientific Affairs, LLC | 4 | $2,244 |
| ITF Therapeutics LLC | 3 | $1,767 |
| Pfizer | 4 | $1,137 |
| Novartis | 4 | $251 |
| Genentech, Inc. | 2 | $180 |
| Ultragenyx Pharmaceutical Inc. | 2 | $48 |
| Biomarin Pharmaceutical Inc. | 1 | $27 |
| PTC Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZOLGENSMA$29,357
- EVRYSDI$24,581
- VYVGART HYTRULO$8,876
- Non-Covered Product$6,783
- SPINRAZA$6,033
- AGAMREE$5,211
- Exondys 51$3,300
- VYVGART$1,650
How this compares
$502,602 in reported general payments places this provider in the 95th percentile of 57 neurology with special qualifications in child neurology providers in Illinois.
See all neurology with special qualifications in child neurology providers in Illinois →
Other neurology with special qualifications in child neurology in Chicago
- Douglas NordliChicago$621K
- Vamshi RaoChicago$124K
- John MillichapChicago$84K
- Sookyong KohChicago$60K
- Elizabeth Berry-KravisChicago$38K
- Colleen BuhrfiendChicago$15K
- Bridget McGowanChicago$11K
- Peter HeydemannChicago$11K
- Divya DesaiChicago$3K
- Joseph CollinsChicago$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.